Results 41 to 50 of about 101,889 (202)

Use of new, once-daily 5-aminosalicylic acid preparations in the treatment of ulcerative colitis. Is there anything new under the sun?

open access: yes, 2009
5-aminosalicylate (5-ASA) agents remain the mainstay treatment in ulcerative colitis (UC). A number of oral 5-ASA agents are commercially available, including azobond pro-drugs, as well as delayed- and controlled-release forms of mesalazine.
Lakatos, Péter László
core   +1 more source

Mycophenolate mofetil combined with steroids: New experiences in the treatment of idiopathic retroperitoneal fibrosis [PDF]

open access: yesVojnosanitetski Pregled, 2007
Background/Aim. Idiopathic retroperitoneal fibrosis (IRF) is an uncommon disease characterized by a retroperitoneal fibrotic tissue that often involve the ureters, leading to the obstructive nephropathy and variable impairment of renal function. Findings
Obrenčević Katarina   +5 more
doaj   +1 more source

Hashimoto's encephalopathy: A long-lasting remission induced by intravenous immunoglobulins [PDF]

open access: yesVojnosanitetski Pregled, 2011
Background. Hashimoto's encephalopathy (HE) is a rare autoimmune syndrome characterized by various neuropsychiatric manifestations, responsive to steroid treatment and associated with Hashimoto's thyroiditis.
Drulović Jelena   +3 more
doaj   +1 more source

Depressive symptoms among patients with schizophrenia in acute and remission phases [PDF]

open access: yesVojnosanitetski Pregled, 2018
Bacground/Aim. Researchers suggest that among people with schizophrenia, the prevalence of depressive symptoms ranges from 7% to 80%. The rate of depressive symptoms among people with schizophrenia varies widely because of the phase of the disease, type ...
Peljto Amir   +3 more
doaj   +1 more source

Favorable subset of acute myeloid leukemia with translocation 8;21: An elusive experience

open access: yesMuller Journal of Medical Sciences and Research, 2015
Background: Risk stratification is critical in the management of acute myeloid leukemia (AML) and among the favorable subset translocations known, 8;21 seems elusive in our clinical practice as regards the response remission status. This led us to review
Nusrat Bashir Khan   +5 more
doaj   +1 more source

Subclinical synovitis detected by magnetic resonance imaging and ultrasonography following clinical remission in patients with rheumatoid arthritis: A retrospective study

open access: yesRheumatology & Autoimmunity, 2021
Background Subjective residual symptoms persist after clinical remission of rheumatoid arthritis (RA) in Japanese patients. Few studies have examined the relationship between these symptoms and subclinical inflammation using high‐sensitivity imaging ...
Masao Nawata   +6 more
doaj   +1 more source

Aminosalicylates for induction of remission or response in Crohn's disease [PDF]

open access: yesCochrane Database of Systematic Reviews, 2016
Randomized trials investigating the efficacy of aminosalicylates for the treatment of mildly to moderately active Crohn's disease have yielded conflicting results. A systematic review was conducted to critically examine current available data on the efficacy of sulfasalazine and mesalamine for inducing remission or clinical response in these patients ...
Wee-Chian, Lim   +3 more
openaire   +2 more sources

Effectiveness for remission maintenance rate and safety of different rituximab regimens for treating anti-neutrophil cytoplasmic antibody-associated vasculitis in Japan: a J-CANVAS study

open access: yesImmunological Medicine
Rituximab (RTX) has been reported to effectively maintain remission in anti-neutrophil cytoplasmic antibody-associated vasculitis (AAV). In this multicenter study involving 57 patients who achieved remission after 24 weeks, we evaluated the effectiveness
Chie Ogita   +34 more
doaj   +1 more source

Induction therapy for adults with acute lymphoblastic leukemia: results of more than 1500 patients from the international ALL trial: MRC UKALL XII/ECOG E2993

open access: yes, 2005
The international acute lymphoblastic leukemia (ALL) study was designed to prospectively define the optimal therapy for adults 60 years of age or younger with newly diagnosed ALL.
Burnett, Alan Kenneth   +41 more
core   +1 more source

Role of the intensive care in treatment of patients with acute myeloid leukemia

open access: yesТерапевтический архив, 2019
Aim. Remission induction can be associate, with the life threatening complications and transfer to ICU of de novo acute myeloid leukemia (AML) patients (pts).
A V Bazhenov   +11 more
doaj   +1 more source

Home - About - Disclaimer - Privacy